ArticleCurrent pharmaceutical biotechnology2025

Exploring the Effects of Chirality of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2- yl)phenyl]imidazolidine-2,4-dione and its Derivatives on the Oncological Target Tankyrase 2. Atomistic Insights.

Xylia Q Peters et al.PubMed ↗Publisher ↗

No numbers read from the abstract.